Procedure for reducing Morbidity and mortality risk

摘要

This Invention relates to procedures,Pharmaceutical compositions and Kits useful for reducing the risk of cardiovascular Morbidity and mortality in men and postmenopausal women and the Morbidity and mortality risk inPostmenopausal women from the combined reduction of breast cancer, osteoporosis and cardiovascular disease by the Administration of estrogen agonists / antagonists.The compositions comprise an estrogen agonist / antagonist and a pharmaceutically acceptable diluent or Carrier vehicle.The compositions and Methods of treatment are effective, while the possibility of adverse effects associated with concomitant Administration of Oestrogen.